Literature DB >> 11303541

Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences.

B Agvall1, U Dahlström.   

Abstract

OBJECTIVE: The aim of the present study was to describe patients considered to have had heart failure (HF), or were being treated for HF, in a defined area in primary health care, e.g. diagnostic procedures, aetiologic diseases and management, and to evaluate whether there is a difference between the genders.
DESIGN: Descriptive retrospective investigation.
SETTING: Atvidaberg community situated in southeast Sweden, 12 400 inhabitants. PATIENTS: 256 patients treated for symptomatic HF. MAIN OUTCOME MEASURES: Prevalence, aetiology, diagnostic procedures and management of HF and differences between the genders.
RESULTS: The diagnosis of HF was based on an objective evaluation of cardiac function in only 31% of the patients. Ischaemic heart disease (IHD) was the predominant associated disease, followed by hypertension. Therapy included diuretics (84%), angiotensin converting enzyme (ACE) inhibitors (56%) and digoxin (40%). Only 52% had optimal doses of ACE inhibitors. Women had a significantly higher mean age and their diagnoses were based on an objective diagnostic test (echocardiography) in only 20%. Women were prescribed ACE inhibitors to a lesser extent (43%) than men (64%) and with a lower optimal dose (44% versus 56% in men).
CONCLUSION: There is still room for improvement in the management of HF in primary health care, especially in women, where the diagnosis is not generally based on an objective evaluation of cardiac function and where the treatment to a lesser extent than in men includes ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303541     DOI: 10.1080/028134301300034549

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  8 in total

Review 1.  Sex and gender differences in myocardial hypertrophy and heart failure.

Authors:  Vera Regitz-Zagrosek; Ute Seeland
Journal:  Wien Med Wochenschr       Date:  2011-03

Review 2.  Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?

Authors:  Khang-Li Looi; Nigel Lever; Anthony Tang; Sharad Agarwal
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

Review 3.  [Heart failure--are there gender aspects?].

Authors:  V Regitz-Zagrosek; E Lehmkuhl; H B Lehmkuhl
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

4.  Atrial fibrillation: the cost of illness in Sweden.

Authors:  Lisa Ericson; Lennart Bergfeldt; Ingela Björholt
Journal:  Eur J Health Econ       Date:  2010-07-01

5.  Gender differences in the etiology of heart failure: A systematic review.

Authors:  Nahid Azad; Anusha Kathiravelu; Shabnam Minoosepeher; Paul Hebert; Dean Fergusson
Journal:  J Geriatr Cardiol       Date:  2011-03       Impact factor: 3.327

6.  Impact Of Sex On Clinical Characteristics And In-Hospital Outcomes In A Multi-Ethnic Southeast Asian Population Of Patients Hospitalized For Acute Heart Failure.

Authors:  Carolyn S P Lam; Peter Chang; Shaw Yang Chia; Ling Ling Sim; Fei Gao; Fong Ling Lee; Ping Chai; Raymond Ching-Chiew Wong; Swee Chong Seow; Gerard Kui Toh Leong; Poh Shuan Daniel Yeo; David Sim; Terrance Chua; Bernard W K Kwok
Journal:  ASEAN Heart J       Date:  2014

Review 7.  Inequity of access to ACE inhibitors in Swedish heart failure patients: a register-based study.

Authors:  Anna Ohlsson; Bertil Lindahl; Marianne Hanning; Ragnar Westerling
Journal:  J Epidemiol Community Health       Date:  2015-08-10       Impact factor: 3.710

8.  Validity of heart failure diagnoses made in 2000-2012 in western Sweden.

Authors:  Maria Schaufelberger; Sofia Ekestubbe; Simon Hultgren; Hans Persson; Ann Reimstad; Mattias Schaufelberger; Annika Rosengren
Journal:  ESC Heart Fail       Date:  2019-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.